Anna U. Loengard - 03 Jan 2023 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
Director
Signature
/s/ Jessica Kirkland, as Attorney-in-Fact
Issuer symbol
CLOV
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 15:59:59 UTC
Previous filing
30 Nov 2022
Next filing
08 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Award $0 +176,991 +948% $0.000000 195,656 03 Jan 2023 Direct F1
holding CLOV Class A Common Stock 800 03 Jan 2023 By Son in a Custodial Account
holding CLOV Class A Common Stock 1,000 03 Jan 2023 By Daughter in a Custodial Account
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on the first anniversary of January 3, 2023, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.